- Home
- VRAX vs RUBI Comparison
VRAX vs RUBI Comparison
Compare VRAX & RUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRAX | RUBI |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United Kingdom | Marshall Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 3.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | VRAX | RUBI |
|---|---|---|
| Price | $0.27 | $0.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | 483.1K | ★ 770.3K |
| Earning Date | 01-01-0001 | 05-06-2020 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,986.00 | ★ $24,139,000.00 |
| Revenue This Year | $217,274.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.26 | $0.77 |
| 52 Week High | $2.29 | $200.70 |
Technical Indicators
Market Signals| Indicator | VRAX | RUBI |
|---|---|---|
| Relative Strength Index (RSI) | 32.38 | N/A |
| Support Level | $0.26 | N/A |
| Resistance Level | $0.30 | N/A |
| Average True Range (ATR) | 0.03 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 6.54 | 0.00 |
Price Performance
Historical ComparisonAbout VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About RUBI Rubico Inc.
Rubico Inc operates as a holding company. It is an eco-conscious international crude oil shipping company. The company's primary business is the ownership and operation of an eco-conscious fleet of tanker vessels designed for enhanced fuel efficiency, reduced greenhouse emissions, and a wide range of environmentally friendly technologies.